Literature DB >> 33792662

Reactive microglia enhance the transmission of exosomal alpha-synuclein via toll-like receptor 2.

Yun Xia1, Guoxin Zhang2, Liang Kou1, Sijia Yin1, Chao Han3, Junjie Hu1, Fang Wan1, Yadi Sun1, Jiawei Wu1, Yunna Li1, Jinsha Huang1, Nian Xiong1, Zhentao Zhang2, Tao Wang1.   

Abstract

Increasing evidence suggests that microglial activation is strongly linked to the initiation and progression of Parkinson's disease (PD). Cell-to-cell propagation of α-synuclein (α-syn) pathology is a highlighted feature of PD, and the focus of such research has been primarily on neurons. However, recent studies as well as the data contained herein suggest that microglia, the primary phagocytes in the brain, play a direct role in the spread of α-syn pathology. Recent data revealed that plasma exosomes derived from PD patients (PD-EXO) carry pathological α-syn and target microglia preferentially. Hence, PD-EXO is likely a key tool for investigating the role of microglia in α-syn transmission. We showed that intrastriatal injection of PD-EXO resulted in the propagation of exosomal α-syn from microglia to neurons following microglia activation. Toll-like receptor 2 (TLR2) in microglia was activated by exosomal α-syn and acted as a crucial mediator of PD-EXO-induced microglial activation. Additionally, partial microglia depletion resulted in a significant decrease of exogenous α-syn in the substantia nigra (SN). Furthermore, exosomal α-syn internalization was initiated by binding to TLR2 of microglia. Excessive α-syn phagocytosis may induce the inflammatory responses of microglia and provide the seed for microglia-to-neuron transmission. Consistently, TLR2 silencing in microglia mitigated α-syn pathology in vivo. Overall, the present data support the idea that the interaction of exosomal α-syn and microglial TLR2 contribute to excessive α-syn phagocytosis and microglial activation, which lead to the further propagation and spread of α-syn pathology, thereby highlighting the pivotal roles of reactive microglia in α-syn transmission.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  microglia; plasma exosomes; toll-like receptor 2; transmission; α-synuclein

Year:  2021        PMID: 33792662     DOI: 10.1093/brain/awab122

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

Review 1.  Microglia in Parkinson's Disease.

Authors:  Nadia Stefanova
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 2.  The Mechanism and Function of Glia in Parkinson's Disease.

Authors:  Xinguo Zhang; Ruiqi Zhang; Maher Un Nisa Awan; Jie Bai
Journal:  Front Cell Neurosci       Date:  2022-05-26       Impact factor: 6.147

3.  The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.

Authors:  Liang Kou; Xiaosa Chi; Yadi Sun; Chao Han; Fang Wan; Junjie Hu; Sijia Yin; Jiawei Wu; Yunna Li; Qiulu Zhou; Wenkai Zou; Nian Xiong; Jinsha Huang; Yun Xia; Tao Wang
Journal:  J Neuroinflammation       Date:  2022-06-06       Impact factor: 9.587

Review 4.  Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies.

Authors:  Sindhu Menon; Sabrina Armstrong; Amir Hamzeh; Naomi P Visanji; Sergio Pablo Sardi; Anurag Tandon
Journal:  Front Neurol       Date:  2022-05-09       Impact factor: 4.086

Review 5.  The Double-Faceted Role of Leucine-Rich Repeat Kinase 2 in the Immunopathogenesis of Parkinson's Disease.

Authors:  Mengfei Zhang; Chaoyi Li; Jie Ren; Huakun Wang; Fang Yi; Junjiao Wu; Yu Tang
Journal:  Front Aging Neurosci       Date:  2022-05-11       Impact factor: 5.702

6.  Evidence of Inflammation in Parkinson's Disease and Its Contribution to Synucleinopathy.

Authors:  Thuy Thi Lai; Yun Joong Kim; Hyeo-Il Ma; Young Eun Kim
Journal:  J Mov Disord       Date:  2021-11-03

7.  NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation.

Authors:  Agata Habas; Srinivasa Reddy Natala; Jon K Bowden-Verhoek; Emily M Stocking; Diana L Price; Wolfgang Wrasidlo; Douglas W Bonhaus; Martin B Gill
Journal:  Int J Inflam       Date:  2022-02-27

Review 8.  Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.

Authors:  Marcell P Szabo; Michiyo Iba; Avindra Nath; Eliezer Masliah; Changyoun Kim
Journal:  Exp Mol Med       Date:  2022-04-08       Impact factor: 12.153

Review 9.  Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism.

Authors:  Zhifu Cui; Xingtao Zhao; Felix Kwame Amevor; Xiaxia Du; Yan Wang; Diyan Li; Gang Shu; Yaofu Tian; Xiaoling Zhao
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 10.  Small but Mighty-Exosomes, Novel Intercellular Messengers in Neurodegeneration.

Authors:  Meena Kumari; Antje Anji
Journal:  Biology (Basel)       Date:  2022-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.